X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ATXI

Closed

Avenue Therapeutics Inc

0.35
+0.15 (+74.74%)
Last Update: 01 Jul 2025 21:12:00
Yesterday: 0.2007
Day's Range: 0.3277 - 0.36
Send
When Written:
 
1.165
Avenue Therapeutics Inc. is a pharmaceutical company that focuses on developing and commercializing intravenous (IV) tramadol, a synthetic opioid analgesic, for the management of moderate to moderately severe pain in acute care settings. The company was founded in 2015 and is headquartered in New York City. Avenue Therapeutics is a subsidiary of InvaGen Pharmaceuticals, a global pharmaceutical company that specializes in the development, manufacturing, and marketing of generic and specialty pharmaceuticals. The company's lead product candidate, IV tramadol, is currently in Phase III clinical trials and has the potential to become an alternative to traditional opioid painkillers, which carry a high risk of addiction and abuse. Avenue Therapeutics aims to provide a safer and more effective pain management option for patients in acute care settings.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X